Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (346)

Clear all filters
Clear all filters

Mifamurtide

Targeted Therapy (Antibody)

Therapeutic Category

Targeted Therapy (Antibody)

Oncology Type

Solid Tumour (Sarcoma/Neuroblastoma)

Drug Class / Mechanism

PDGFR / GD2 Targeting Agent

Mirdametinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

MEK1/2 Inhibitor

Mirvetuximab Soravtansine

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Solid Tumour

Drug Class / Mechanism

ADC

MK-2206 (AKT Inhibitor)

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

AKT Inhibitor

Motesanib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

Multi-Kinase / Anti-Angiogenic Inhibitor

Nadofaragene Firadenovec

Immunotherapy (Gene Therapy)

Therapeutic Category

Immunotherapy (Gene Therapy)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Non-Replicating Adenoviral Vector Delivering Interferon Alfa-2b

Naporafenib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

BRAF / MEK Inhibitor

Naxitamab

Targeted Therapy (Antibody)

Therapeutic Category

Targeted Therapy (Antibody)

Oncology Type

Solid Tumour (Sarcoma/Neuroblastoma)

Drug Class / Mechanism

PDGFR / GD2 Targeting Agent

Necitumumab

Targeted Therapy (Antibody)

Therapeutic Category

Targeted Therapy (Antibody)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Anti-EGFR mAb

Neratinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

EGFR / HER2 Tyrosine Kinase Inhibitor

Nimotuzumab

Targeted Therapy (Antibody)

Therapeutic Category

Targeted Therapy (Antibody)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Anti-EGFR mAb

Nintedanib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

Multi-Kinase / Anti-Angiogenic Inhibitor